MiR-17 Knockdown Promotes Vascular Smooth Muscle Cell Phenotypic Modulation Through Upregulated Interferon Regulator...

Area of Science:

• Molecular biology
• Cardiovascular research
• RNA biology

Background:

• MicroRNA-17 (miR-17) is implicated in tumorgenesis, inflammation, and angiogenesis.
• Its role in vascular smooth muscle cell (VSMC) phenotypic modulation remains unexplored.

Purpose of the Study:

• To investigate the effect and mechanism of miR-17 on VSMC phenotypic modulation.
• To explore miR-17 as a potential therapeutic target for intimal hyperplasia.

Main Methods:

• Real-time polymerase chain reaction (RT-PCR) to assess miR-17 expression.
• Loss-of-function studies to evaluate miR-17 knockdown effects.
• Bioinformatics analysis and luciferase assays to identify miR-17 targets.
• Western blot analysis for protein expression.

Main Results:

• miR-17 expression was downregulated in VSMCs under PDGF-BB stimulation and in wire-injured carotid arteries.
• miR-17 knockdown enhanced VSMC phenotypic modulation, increasing proliferation and migration.
• miR-17 directly targets Interferon Regulator Factor 9 (IRF9).
• Upregulated IRF9 mediated the effects of miR-17 knockdown on VSMC phenotype.

Conclusions:

• miR-17 knockdown accelerates VSMC phenotypic modulation via direct targeting of IRF9.
• miR-17 represents a novel therapeutic target for managing intimal hyperplasia.